NASDAQ : FOLD
Amicus Therapeutics, Inc. — Financial statements
Healthcare · Biotechnology · United States
Last price 14.49 USD (At close: Apr 24, 2026) · Market cap 4.55B
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Financial statements
Amicus Therapeutics, Inc. (FOLD) reported revenue of 634.21M USD (TTM). Five years of income statement, balance sheet, cash flow and ratios below.
Income statement
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Revenue | 634.21M | 634.21M | 528.29M | 399.36M | 329.23M | 305.51M |
| Cost of Revenue | 72.93M | 72.93M | 52.94M | 37.33M | 38.60M | 34.47M |
| Gross Profit | 561.28M | 561.28M | 475.35M | 362.03M | 290.63M | 271.05M |
| Selling, General & Admin | 383.49M | 383.49M | 323.38M | 275.27M | 213.04M | 192.71M |
| Research & Development | 135.84M | 135.84M | 109.36M | 152.38M | 276.68M | 272.05M |
| Operating Expenses | 526.79M | 526.79M | 441.29M | 435.52M | 495.06M | 470.97M |
| Operating Income | 34.49M | 34.49M | 34.06M | -73.49M | -204.43M | -199.92M |
| Interest Expense | -46.16M | -46.16M | -49.60M | -50.15M | -37.12M | -32.47M |
| Interest & Investment Income | 3.32M | 3.32M | 5.41M | 7.08M | 3.02M | 509.00K |
| Other Non Operating Income (Expenses) | 10.24M | 10.24M | -9.44M | -15.89M | 4.18M | -2.90M |
| EBT Excluding Unusual Items | 1.89M | 1.89M | -19.57M | -132.45M | -234.34M | -234.78M |
| Merger & Restructuring Charges | -9.19M | |||||
| Asset Writedown | -1.70M | -1.70M | -1.13M | -6.62M | ||
| Other Unusual Items | -16.52M | -1.08M | -6.77M | |||
| Pretax Income | 191.00K | 191.00K | -28.76M | -150.10M | -242.04M | -241.55M |
| Income Tax Expense | 27.30M | 27.30M | 27.35M | 1.48M | -5.47M | 8.91M |
| Net Income | -27.11M | -27.11M | -56.11M | -151.58M | -236.57M | -250.46M |
| Net Income to Common | -27.11M | -27.11M | -56.11M | -151.58M | -236.57M | -250.46M |
| Shares Outstanding (Basic) | 308.36M | 308.36M | 304.38M | 295.16M | 289.06M | 271.42M |
| Shares Outstanding (Diluted) | 308.36M | 308.36M | 304.38M | 295.16M | 289.06M | 271.42M |
| EPS (Basic) | -0.09 | -0.09 | -0.18 | -0.51 | -0.82 | -0.92 |
| EPS (Diluted) | -0.09 | -0.09 | -0.18 | -0.51 | -0.82 | -0.92 |
| Free Cash Flow | 29.85M | 29.85M | -37.44M | -76.53M | -170.34M | -206.38M |
| Free Cash Flow Per Share | 0.10 | 0.10 | -0.12 | -0.26 | -0.59 | -0.76 |
| Gross Margin | 88.50% | 88.50% | 89.98% | 90.65% | 88.28% | 88.72% |
| Operating Margin | 5.44% | 5.44% | 6.45% | -18.40% | -62.09% | -65.44% |
| Profit Margin | -4.28% | -4.28% | -10.62% | -37.96% | -71.85% | -81.98% |
| Free Cash Flow Margin | 4.71% | 4.71% | -7.09% | -19.16% | -51.74% | -67.55% |
| EBITDA | 41.95M | 41.95M | 42.61M | -65.62M | -199.08M | -193.71M |
| EBITDA Margin | 6.62% | 6.62% | 8.07% | -16.43% | -60.47% | -63.41% |
| D&A For EBITDA | 7.46M | 7.46M | 8.55M | 7.87M | 5.34M | 6.21M |
| EBIT | 34.49M | 34.49M | 34.06M | -73.49M | -204.43M | -199.92M |
| EBIT Margin | 5.44% | 5.44% | 6.45% | -18.40% | -62.09% | -65.44% |
| Effective Tax Rate | 14,293.72% | 14,293.72% |
Balance sheet
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Cash & Equivalents | 214.01M | 214.01M | 213.75M | 246.99M | 148.81M | 245.20M |
| Short-Term Investments | 79.53M | 79.53M | 36.19M | 39.21M | 144.78M | 237.30M |
| Cash & Short-Term Investments | 293.54M | 293.54M | 249.95M | 286.20M | 293.60M | 482.50M |
| Receivables | 115.31M | 115.31M | 101.10M | 87.63M | 66.20M | 52.67M |
| Inventory | 228.82M | 228.82M | 118.78M | 59.70M | 23.82M | 26.82M |
| Prepaid Expenses | 38.51M | 38.51M | 34.91M | 49.53M | 40.21M | 34.85M |
| Total Current Assets | 676.17M | 676.17M | 504.74M | 483.06M | 423.82M | 596.83M |
| Property, Plant & Equipment | 48.25M | 48.25M | 51.66M | 57.98M | 60.31M | 63.08M |
| Goodwill | 197.80M | 197.80M | 197.80M | 197.80M | 197.80M | 197.80M |
| Other Intangible Assets | 13.91M | 13.91M | 17.20M | 20.49M | 23.00M | |
| Long-Term Deferred Charges | 23.00M | |||||
| Other Long-Term Assets | 13.74M | 13.74M | 13.64M | 18.55M | 19.24M | 24.43M |
| Total Assets | 949.87M | 949.87M | 785.03M | 777.88M | 724.17M | 905.14M |
| Accounts Payable | 28.63M | 28.63M | 12.95M | 15.12M | 15.41M | 21.51M |
| Accrued Expenses | 159.97M | 159.97M | 96.70M | 121.44M | 80.23M | 87.80M |
| Current Portion of Leases | 8.74M | 8.74M | 8.46M | 8.32M | 8.55M | 7.41M |
| Current Income Taxes Payable | 28.81M | 28.81M | 18.11M | 12.43M | 5.94M | 6.15M |
| Other Current Liabilities | 11.68M | 11.68M | 12.49M | 10.37M | 28.88M | 23.10M |
| Total Current Liabilities | 237.83M | 237.83M | 148.70M | 167.69M | 139.02M | 145.97M |
| Long-Term Debt | 392.66M | 392.66M | 390.11M | 387.86M | 391.99M | 389.36M |
| Long-Term Leases | 40.96M | 40.96M | 45.08M | 48.88M | 51.58M | 43.36M |
| Long-Term Unearned Revenue | 5.91M | |||||
| Long-Term Deferred Tax Liabilities | 4.93M | |||||
| Other Long-Term Liabilities | 4.18M | 4.18M | 7.10M | 13.28M | 18.53M | 8.24M |
| Total Liabilities | 675.63M | 675.63M | 590.99M | 617.71M | 601.12M | 597.77M |
| Common Stock | 3.04M | 3.04M | 2.94M | 2.92M | 2.81M | 2.81M |
| Additional Paid-In Capital | 3.01B | 3.01B | 2.93B | 2.84B | 2.66B | 2.60B |
| Retained Earnings | -2.77B | -2.77B | -2.74B | -2.68B | -2.53B | -2.30B |
| Treasury Stock | -71.00K | -71.00K | ||||
| Comprehensive Income & Other | 24.11M | 24.11M | 5.17M | 5.31M | -12.02M | 5.06M |
| Shareholders' Equity | 274.24M | 274.24M | 194.04M | 160.17M | 123.05M | 307.37M |
| Total Liabilities & Equity | 949.87M | 949.87M | 785.03M | 777.88M | 724.17M | 905.14M |
| Total Debt | 442.36M | 442.36M | 443.64M | 445.06M | 452.12M | 440.13M |
| Net Cash (Debt) | -148.83M | -148.83M | -193.70M | -158.86M | -158.53M | 42.37M |
| Net Cash Per Share | -0.48 | -0.48 | -0.64 | -0.54 | -0.55 | 0.16 |
| Filing Date Shares Outstanding | 314.00M | 314.00M | 300.12M | 295.38M | 282.71M | 280.03M |
| Total Common Shares Outstanding | 310.85M | 310.85M | 299.04M | 293.59M | 281.11M | 278.91M |
| Working Capital | 438.35M | 438.35M | 356.03M | 315.37M | 284.80M | 450.86M |
| Book Value Per Share | 0.88 | 0.88 | 0.65 | 0.55 | 0.44 | 1.10 |
| Tangible Book Value | 62.53M | 62.53M | -20.95M | -58.11M | -97.75M | 109.57M |
| Tangible Book Value Per Share | 0.20 | 0.20 | -0.07 | -0.20 | -0.35 | 0.39 |
| Land | 3.19M | |||||
| Machinery | 25.28M | 25.28M | 25.13M | 24.15M | 23.63M | 25.62M |
| Construction In Progress | 262.00K | 3.81M | 4.16M | 8.23M | ||
| Leasehold Improvements | 33.07M | 33.07M | 32.36M | 28.03M | 24.16M | 24.17M |
Cash flow statement
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Net Income | -27.11M | -27.11M | -56.11M | -151.58M | -236.57M | -250.46M |
| Depreciation & Amortization | 7.46M | 7.46M | 8.55M | 7.87M | 5.34M | 6.21M |
| Other Amortization | 2.57M | 2.57M | 2.26M | 2.62M | 2.63M | 2.49M |
| Asset Writedown & Restructuring Costs | -1.14M | -1.14M | 9.21M | 2.73M | 18.18M | |
| Stock-Based Compensation | 87.41M | 87.41M | 84.91M | 86.08M | 76.51M | 57.84M |
| Other Operating Activities | 3.59M | 3.59M | 16.23M | 31.19M | 7.21M | 10.37M |
| Change in Accounts Receivable | -5.86M | -5.86M | -19.48M | -20.11M | -17.33M | -8.19M |
| Change in Inventory | -111.48M | -111.48M | -73.65M | -44.61M | -5.34M | -7.79M |
| Change in Accounts Payable | 82.78M | 82.78M | -16.52M | 49.20M | -6.38M | 7.43M |
| Change in Other Net Operating Assets | -5.07M | -5.07M | 10.71M | -32.46M | -10.83M | -20.39M |
| Operating Cash Flow | 33.15M | 33.15M | -33.89M | -69.09M | -166.57M | -202.49M |
| Capital Expenditures | -3.30M | -3.30M | -3.55M | -7.44M | -3.77M | -3.88M |
| Sale of Property, Plant & Equipment | 3.41M | |||||
| Investment in Securities | -43.14M | -43.14M | 2.99M | 105.50M | 92.67M | 82.64M |
| Investing Cash Flow | -46.43M | -46.43M | -560.00K | 98.06M | 92.32M | 78.76M |
| Long-Term Debt Issued | 387.36M | |||||
| Long-Term Debt Repaid | -272.00K | -272.00K | -97.00K | -408.32M | -283.00K | -479.00K |
| Net Debt Issued (Repaid) | -272.00K | -272.00K | -97.00K | -20.96M | -283.00K | -479.00K |
| Issuance of Common Stock | 19.20M | 19.20M | 27.24M | 103.21M | 4.31M | 229.21M |
| Repurchase of Common Stock | -18.32M | -18.32M | -22.02M | -17.92M | -11.49M | -15.01M |
| Other Financing Activities | -2.65M | -1.65M | ||||
| Financing Cash Flow | 610.00K | 610.00K | 5.12M | 61.68M | -7.46M | 212.07M |
| Foreign Exchange Rate Adjustments | 13.28M | 13.28M | -4.03M | 6.31M | -14.62M | -5.05M |
| Net Cash Flow | 600.00K | 600.00K | -33.36M | 96.96M | -96.34M | 83.29M |
| Free Cash Flow | 29.85M | 29.85M | -37.44M | -76.53M | -170.34M | -206.38M |
| Free Cash Flow Margin | 4.71% | 4.71% | -7.09% | -19.16% | -51.74% | -67.55% |
| Free Cash Flow Per Share | 0.10 | 0.10 | -0.12 | -0.26 | -0.59 | -0.76 |
| Levered Free Cash Flow | 47.84M | 47.84M | 5.41M | -25.89M | -94.23M | -84.97M |
| Unlevered Free Cash Flow | 74.12M | 74.12M | 34.14M | 2.84M | -73.66M | -67.16M |
| Cash Interest Paid | 43.61M | 43.61M | 58.96M | 36.09M | 34.36M | 30.47M |
| Cash Income Tax Paid | 14.89M | 14.89M | 8.21M | 8.53M | 1.61M | 20.03M |
| Change in Working Capital | -39.63M | -39.63M | -98.94M | -47.99M | -39.88M | -28.94M |
Ratios
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Market Capitalization | 4.55B | 4.40B | 2.81B | 4.16B | 3.43B | 3.22B |
| Enterprise Value | 4.70B | 4.58B | 3.01B | 4.34B | 3.53B | 3.10B |
| Last Close Price | 14.24 | 9.42 | 14.19 | 12.21 | 11.55 | |
| Forward PE | 39.70 | 59.68 | 87.63 | |||
| PS Ratio | 7.17 | 6.95 | 5.33 | 10.42 | 10.42 | 10.53 |
| PB Ratio | 16.42 | 16.06 | 14.51 | 25.98 | 27.88 | 10.47 |
| P/TBV Ratio | 72.76 | 70.44 | 29.37 | |||
| P/FCF Ratio | 152.43 | 147.56 | ||||
| P/OCF Ratio | 137.27 | 132.89 | ||||
| EV/Sales Ratio | 7.41 | 7.23 | 5.70 | 10.86 | 10.71 | 10.15 |
| EV/EBITDA Ratio | 112.00 | 109.26 | 70.63 | |||
| EV/EBIT Ratio | 136.23 | 132.89 | 88.35 | |||
| EV/FCF Ratio | 157.42 | 153.56 | ||||
| Debt / Equity Ratio | 1.61 | 1.61 | 2.29 | 2.78 | 3.67 | 1.43 |
| Debt / EBITDA Ratio | 8.73 | 8.73 | 8.61 | |||
| Debt / FCF Ratio | 14.82 | 14.82 | ||||
| Net Debt / Equity Ratio | 0.54 | 0.54 | 1.00 | 0.99 | 1.29 | -0.14 |
| Net Debt / EBITDA Ratio | 3.55 | 3.55 | 4.55 | -2.42 | -0.80 | 0.22 |
| Net Debt / FCF Ratio | 4.99 | 4.99 | -5.17 | -2.08 | -0.93 | 0.20 |
| Asset Turnover | 0.73 | 0.73 | 0.68 | 0.53 | 0.40 | 0.34 |
| Inventory Turnover | 0.42 | 0.42 | 0.59 | 0.89 | 1.52 | 1.49 |
| Quick Ratio | 1.72 | 1.72 | 2.36 | 2.23 | 2.59 | 3.67 |
| Current Ratio | 2.84 | 2.84 | 3.39 | 2.88 | 3.05 | 4.09 |
| Return on Equity (ROE) | -11.58% | -11.58% | -31.68% | -107.04% | -109.93% | -84.37% |
| Return on Assets (ROA) | 2.48% | 2.48% | 2.72% | -6.12% | -15.68% | -13.95% |
| Return on Invested Capital (ROIC) | -1,176.15% | -1,207.57% | 9.64% | -24.47% | -74.80% | -78.42% |
| Return on Capital Employed (ROCE) | 4.80% | 4.80% | 5.40% | -12.00% | -34.90% | -26.30% |
| Earnings Yield | -0.60% | -0.61% | -1.99% | -3.64% | -6.90% | -7.78% |
| FCF Yield | 0.66% | 0.68% | -1.33% | -1.84% | -4.97% | -6.41% |
| Buyback Yield / Dilution | -1.31% | -1.31% | -3.12% | -2.11% | -6.50% | -4.85% |